期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

不可切除Ⅲ期N_2非小细胞肺癌治疗新模式 被引量：1

New therapy patterns of unresectable stage Ⅲ-N2 non-small cell lung cancer
暂未订购
导出
作者 王思愚
机构地区 中山大学肿瘤医院胸科
出处 《中国肺癌杂志》 CAS 2005年第5期405-407,共3页 Chinese Journal of Lung Cancer
基金 广东省科技厅重点科技项目(2KM04402S 2005B30301002)资助
关键词 Ⅲ期N2非小细胞肺癌 不可切除 纵隔淋巴结转移 癌治疗 NSCLC 5年生存率 团块状阴影 cell 肺癌患者
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献17

  • 1Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg,1988,96(3):440-447.
  • 2王思愚,吴一龙,戎铁华,黄植藩,区伟.Ⅲ期N2非小细胞肺癌的外科治疗[J].中华肿瘤杂志,2002,24(6):605-607. 被引量：25
  • 3Choy H, Curran W, Scott CB, et al. Preliminary report of locally advanced multimodality protocol (LAMP): a randomized phase Ⅱ study of three chemo-radiotherapy regimens with paclitaxel, carboplatin, and thoracic radiotherapy for patients with locally advanced non-small cell lung cancer. Proc Am Soc Clin Oncol,2002,21:291a.
  • 4Vokes E, Herndon J, Kelly M, et al. Induction chemotherapy followed by concomtant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer: Initial analysis of a randomized phase Ⅲ trail. Proc Am Soc Clin Oncol,2004,23:7005a.
  • 5Swann RS, Machtay M, Komaki R, et al. Impact of overall treatment time during concurrent chemoradiotherapy for locally advanced NSCLC: an RTOG secondary analysis. Lung Cancer,2005,49(Suppl 2):S17.
  • 6Gervais R, Ducolone A, Lechevalier T, et al. Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatin (P)]: Final results of a randomized phase Ⅲ trial in stage Ⅲ unresectable non small cell lung cancer (NSCLC). Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT. Lung Cancer,2005,49(Suppl 2):S16.
  • 7Gandara DR, Chansky K, Gaspar LE, et al. Long term survival in stage Ⅲb non-small cell lung cancer (NSCLC) treated with consolidation docetaxel following concurrent chemoradiotherapy (SWOG S9504). Proc Am Soc Clin Oncol,2005,24:7059a.
  • 8Kelly K, Gaspar LE, Chanksy K, et al. A randomized phase Ⅲ trail of cisplatin/etoposide plus radiation therapy followed by consolidation docetaxel with maintenance therapy with gefitinib or placebo in patients with locally advanced unresectable stage Ⅲ non-small cell lung cancer. Lung Cancer,2005,49(Suppl 2):S64.
  • 9Wang SY, Ou W, Rong TH. Induction chemotherapy with NVB and carboplatin for unresectable stage Ⅲ-N2 non-small cell lung cancer: Result of phase Ⅱ trail. Lung Cancer,2005,49(Suppl 2):S286.
  • 10Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages ⅢA (N2) and ⅢB non-small-cell lung cancer: mature results of Southwest Oncology Group phase Ⅱ study 8805. J Clin Oncol,1995,13(8):1880-1892.

二级参考文献4

共引文献24

同被引文献56

  • 1沈德义,寿伟臻,裴广廷.Ⅲ期(N_2)非小细胞肺癌切除后辅助治疗的探讨[J].实用肿瘤学杂志,1995,9(2):60-60. 被引量：9
  • 2于世英.肺癌分子靶向治疗药物的研究进展[J].医药导报,2006,25(7):654-656. 被引量：11
  • 3Goldstraw P, Crowley J, Chansky K, et al. The IASLC LungCancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant turnouts[J]. J Thorac Oncol, 2007,2(8):706-714.
  • 4Casali C, Stefani Natali, et al . Prognostic factors in surgically resected (Nz)NSCLC: the importance of patterns of mediastinal lymph nodes metastases[J]. EurJ Cardiothorac Surg J, 2005, 28(1) :33-38.
  • 5Dautzenberg B, Arriagada R, Chammard A, et al. A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma [J].Cancer, 1999, 86(2): 265-273.
  • 6Robinson LA, Ruckdeschel JC, Wagner H, et al. Treatment of non-small cell lung cancer-stage A. ACCP Evidencebased clinical practice guidelines (2nd edition)[J]. Chest, 2007,132,243S-265S.
  • 7Rigas JR, Kelly K. Current treatment paradigms for locally advanced non-small cell lung cancer[J]. J Thorac Oncol , 2007,2(Suppl 2) : S77-S85.
  • 8Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage Ⅲ non-small cell .lung cancer~ Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines [J]. Chest, 2013,143(5 Suppl):e314S-340S.
  • 9Yoshino I, Yoshida S, Miyaoka E, et al . Surgical outcome of stage ⅢA- cN2/pN2 nonesmall-cell lung cancer patients in Japanese lung cancer registry study in 2004 [J]. J Thorac Oncol, 2012,7(9) :850-855.
  • 10Toloza EM, Hardpole L, McCroy DC. Non invasive staging of non-small cell lung cancer: a review of the current evidence[J]. Chest, 2003,123(2) : 137s-146s.

引证文献1

二级引证文献7

中国肺癌杂志
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部